Everything we've seen

1. ·Sep 14, 3:20 PMstreamnews

   3 Profitable Stocks to Keep an Eye On

   Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

2. ·Sep 14, 3:20 PMstreamnews

   FOMC Meeting Takes Center Stage As Earnings Fade

   Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

3. ·Sep 14, 3:20 PMstreamnews

   Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

   UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

4. ·Sep 14, 3:20 PMstreamnews

   Five Dividend Stocks Crushing Inflation With Consistent Dividend Payout Growth

   A static dividend yield quietly loses ground every month inflation climbs, but five companies have been raising their payouts fast enough to fight back. The question is which ones have the cash flow to keep doing it.

5. ·Sep 14, 3:05 PMstreamnews

   3 Profitable Stocks to Keep an Eye On

   Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

6. ·Sep 14, 3:05 PMstreamnews

   FOMC Meeting Takes Center Stage As Earnings Fade

   Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

7. ·Sep 14, 3:05 PMstreamnews

   Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

   UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

8. ·Sep 14, 3:05 PMstreamnews

   Five Dividend Stocks Crushing Inflation With Consistent Dividend Payout Growth

   A static dividend yield quietly loses ground every month inflation climbs, but five companies have been raising their payouts fast enough to fight back. The question is which ones have the cash flow to keep doing it.

9. ·Sep 14, 2:50 PMstreamnews

   3 Profitable Stocks to Keep an Eye On

   Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

10. ·Sep 14, 2:50 PMstreamnews

    FOMC Meeting Takes Center Stage As Earnings Fade

    Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

11. ·Sep 14, 2:50 PMstreamnews

    Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

    UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

12. ·Sep 14, 2:50 PMstreamnews

    Five Dividend Stocks Crushing Inflation With Consistent Dividend Payout Growth

    A static dividend yield quietly loses ground every month inflation climbs, but five companies have been raising their payouts fast enough to fight back. The question is which ones have the cash flow to keep doing it.

13. ·Sep 14, 2:35 PMstreamnews

    3 Profitable Stocks to Keep an Eye On

    Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

14. ·Sep 14, 2:35 PMstreamnews

    FOMC Meeting Takes Center Stage As Earnings Fade

    Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

15. ·Sep 14, 2:35 PMstreamnews

    Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

    UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

16. ·Sep 14, 2:35 PMstreamnews

    Five Dividend Stocks Crushing Inflation With Consistent Dividend Payout Growth

    A static dividend yield quietly loses ground every month inflation climbs, but five companies have been raising their payouts fast enough to fight back. The question is which ones have the cash flow to keep doing it.

17. ·Sep 14, 2:20 PMstreamnews

    3 Profitable Stocks to Keep an Eye On

    Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

18. ·Sep 14, 2:20 PMstreamnews

    FOMC Meeting Takes Center Stage As Earnings Fade

    Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

19. ·Sep 14, 2:20 PMstreamnews

    Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

    UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

20. ·Sep 14, 2:20 PMstreamnews

    UnitedHealth Earnings Growth Outlook Unlikely to Change, UBS Says

    UnitedHealth (UNH) has been facing investor questions surrounding the upcoming release of Medicare A

21. ·Sep 14, 2:20 PMstreamnews

    Here's Why Tenet Healthcare Shares are Attracting Investors Now

    THC's shares are gaining on higher-acuity demand, strong commercial revenues and USPI's continued expansion.

22. ·Sep 14, 2:06 PMstreamnews

    3 Profitable Stocks to Keep an Eye On

    Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

23. ·Sep 14, 2:06 PMstreamnews

    FOMC Meeting Takes Center Stage As Earnings Fade

    Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

24. ·Sep 14, 2:06 PMstreamnews

    Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

    UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

25. ·Sep 14, 1:50 PMstreamnews

    3 Profitable Stocks to Keep an Eye On

    Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

26. ·Sep 14, 1:50 PMstreamnews

    FOMC Meeting Takes Center Stage As Earnings Fade

    Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

27. ·Sep 14, 1:50 PMstreamnews

    Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

    UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

28. ·Sep 14, 1:35 PMstreamnews

    3 Profitable Stocks to Keep an Eye On

    Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

29. ·Sep 14, 1:35 PMstreamnews

    FOMC Meeting Takes Center Stage As Earnings Fade

    Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

30. ·Sep 14, 1:35 PMstreamnews

    Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

    UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

31. ·Sep 14, 1:20 PMstreamnews

    3 Profitable Stocks to Keep an Eye On

    Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

32. ·Sep 14, 1:20 PMstreamnews

    FOMC Meeting Takes Center Stage As Earnings Fade

    Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

33. ·Sep 14, 1:20 PMstreamnews

    Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

    UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

34. ·Sep 14, 1:20 PMstreamnews

    Which dow jones stocks are moving on Monday?

    Uncover the latest developments among dow jones stocks in today's session. Stay tuned to the dow jones index's top gainers and losers on Monday.

35. ·Sep 14, 1:05 PMstreamnews

    3 Profitable Stocks to Keep an Eye On

    Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

36. ·Sep 14, 1:05 PMstreamnews

    FOMC Meeting Takes Center Stage As Earnings Fade

    Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

37. ·Sep 14, 1:05 PMstreamnews

    Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

    UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

38. ·Sep 14, 12:50 PMstreamnews

    3 Profitable Stocks to Keep an Eye On

    Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

39. ·Sep 14, 12:50 PMstreamnews

    FOMC Meeting Takes Center Stage As Earnings Fade

    Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

40. ·Sep 14, 12:50 PMstreamnews

    Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

    UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

41. ❖Sep 14, 12:40 PMnewsvia finnhub

    Which dow jones stocks are moving on Monday?

    Uncover the latest developments among dow jones stocks in today's session. Stay tuned to the dow jones index's top gainers and losers on Monday.

42. ❖Sep 14, 12:27 PMnewsvia finnhub

    Here's Why Tenet Healthcare Shares are Attracting Investors Now

    THC's shares are gaining on higher-acuity demand, strong commercial revenues and USPI's continued expansion.

43. ❖Sep 14, 11:55 AMnewsvia finnhub

    UnitedHealth Earnings Growth Outlook Unlikely to Change, UBS Says

    UnitedHealth (UNH) has been facing investor questions surrounding the upcoming release of Medicare A

44. ?Sep 14, 10:26 AMdecisionconsidered

    Agent 20 — SIR Price/Volume — skip

    [distribution] The 20-day PV path traces a clear down-and-right drift: the stock peaked at $401.73 on 2026-08-14 and has made a sequence of lower closes into today's $379.09, with the heaviest volume concentrated on down days. Critically, the three most recent sessions (2026-09-09 through 2026-09-11) show net price decline of −3.6% on expanding volume — 7.7M on 2026-09-09, then 4.3M, then 7.5M today — all of them DOWN days, confirming sellers are absorbing every rally attempt on elevated supply. Today's bar alone (7.5M shares, z-score +2.14 vs. the trailing 20-day ADV of 4.6M) represents the second-highest single-session volume in the window and closes at a new 20-day low of $379.09, extending the down-and-right path rather than reversing it. Risks: This distribution read would be invalidated by a high-volume reversal session (≥6M shares) closing back above the $393–$396 range, which would suggest the selling exhausted itself and fresh demand has stepped in. Additionally, a macro regime shift — such as the T10Y2Y steepening sharply above its 24-month trend — could lift the Health Care defensive sector broadly and overwhelm the stock-specific supply pressure.

45. ?Sep 14, 9:38 AMdecisionconsidered

    Agent 20 — SIR Price/Volume — skip

    [distribution] The 20-day PV path tells a clear distributive story: the price peaked near $401–$402 (2026-08-14, 2026-08-26, 2026-09-02–03) on progressively lighter volume (3.5M, 3.6M, 3.3M–5.5M), while every meaningful down-leg has been accompanied by heavier volume. The three most recent sessions — 2026-09-09 (−1.94%, 7.7M), 2026-09-10 (−1.22%, 4.3M), and today 2026-09-11 (−2.37%, 7.5M) — form a sub-path of net −6.3 points on volumes that dwarf the up-day volumes in the same period; today's 7.5M (z-score +2.14 vs. 20d ADV of 4.6M) is the second-heaviest print in the window, matching the 2026-09-09 distribution candle. The overall path has drifted from ~$401 to ~$379 while down-day volume has consistently outpaced up-day volume, completing all three bearish-confirmation criteria required even under a notional bull-regime override. Risks: A decisive reclaim of the $393–$401 cluster on volume ≥ 6M would signal that today's sell-off was a shakeout rather than distribution, invalidating the bearish read. Additionally, if the T10Y2Y spread were to steepen sharply (moving back toward trend), the defensive/health-care sector bid could return and absorb supply at current levels.

46. ❖Sep 14, 8:45 AMnewsvia finnhub

    Buy These 5 Top-Ranked Wide Moat Stocks to Strengthen Your Portfolio

    CAT, TSM, UNH, TER and ZBRA are five wide moat stocks that stand out for durable advantages, strong growth prospects and favorable demand across key markets.

47. ?Sep 14, 7:01 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

48. !Sep 14, 7:01 AMsignalseverity 0.10

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

49. ?Sep 14, 7:00 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

50. !Sep 14, 7:00 AMsignalseverity 0.10

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

51. ❖Sep 14, 7:00 AMnewsvia finnhub

    UnitedHealth Group Inc's Dividend Analysis

    UnitedHealth Group Inc (NYSE:UNH) recently announced a total dividend of $2.32 per share, with the ex-dividend date set for 2026-09-14. This amount consists of $2.32 per share in cash dividends, payable on 2026-09-22. Investors should note that the ex-dividend date of 2026-09-14 means shareholders must own the stock before that date to qualify for the payment.

52. ❖Sep 13, 11:26 AMnewsvia finnhub

    Five Dividend Stocks Crushing Inflation With Consistent Dividend Payout Growth

    A static dividend yield quietly loses ground every month inflation climbs, but five companies have been raising their payouts fast enough to fight back. The question is which ones have the cash flow to keep doing it.

53. ❖Sep 12, 2:30 PMnewsvia finnhub

    Dear UnitedHealth Stock Fans, Mark Your Calendars for October 1

    UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

54. ❖Sep 12, 7:00 AMnewsvia finnhub

    FOMC Meeting Takes Center Stage As Earnings Fade

    Wall Street Week Ahead: key market events, Fed rate decision, retail sales, earnings, IPOs, dividends & volatility watchlists. See more here.

55. ❖Sep 11, 9:39 PMnewsvia finnhub

    3 Profitable Stocks to Keep an Eye On

    Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.

56. ?Sep 11, 6:03 PMdecisionconsidered

    Agent 20 — SIR Price/Volume — skip

    [distribution] The 20-day PV path reveals a textbook distribution signature: down-days consistently print on heavier volume than up-days, and the path drifts progressively lower-and-right through price-volume space. Specifically, the three heaviest volume sessions in the window — 2026-09-09 (7.7M, -1.94%), 2026-09-11 (7.4M, -2.37%), and 2026-09-08 (7.0M, +0.93%) — tell the story clearly: the single meaningful up-day at elevated volume (Sep 8) was immediately reversed by two consecutive heavy-volume down-days totaling -4.31% of price destruction, pulling the close from $400.84 all the way to $379.09. The earlier cluster from ~Aug 24–Sep 4 ($396–$401 range, ADV-like volumes of 2.5M–5.5M) has been decisively broken to the downside on expanding volume, the inverse of a bullish cluster_break_up — price has now exited that cluster downward, with today's 7.4M (z-score +2.11 vs. 20d mean of 4.6M) confirming aggressive supply. Risks: This distribution read would be invalidated by a strong-volume reversal session — specifically a close back above $390–$393 on volume ≥ 7M, which would suggest the today's down-thrust was a capitulation/flush rather than continuation selling. Additionally, a macro regime shift (e.g., a sudden drop in the elevated 5Y inflation breakeven back toward trend) could relieve rate-sensitive sector pressure and neutralize the bearish path signal.

57. ❖Sep 11, 5:45 PMnewsvia finnhub

    UnitedHealth Group (UNH) Stock Drops Despite Market Gains: Important Facts to Note

    In the latest trading session, UnitedHealth Group (UNH) closed at $379.09, marking a -2.37% move from the previous day.

58. ?Sep 11, 4:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

59. !Sep 11, 4:20 PMsignalseverity 0.10

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

60. ?Sep 11, 4:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

61. !Sep 11, 4:20 PMsignalseverity 0.10

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

62. ?Sep 11, 3:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

63. !Sep 11, 3:20 PMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

64. ?Sep 11, 3:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

65. !Sep 11, 3:20 PMsignalseverity 0.11

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

66. ❖Sep 11, 3:10 PMnewsvia finnhub

    Friday's session: top gainers and losers in the dow jones index

    Stay informed about the performance of the dow jones index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights.

67. ❖Sep 11, 3:05 PMnewsvia finnhub

    Top S&P500 movers in Friday's session

    Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.

68. ?Sep 11, 2:21 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

69. !Sep 11, 2:21 PMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

70. ?Sep 11, 2:21 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

71. !Sep 11, 2:21 PMsignalseverity 0.11

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

72. ?Sep 11, 1:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

73. !Sep 11, 1:20 PMsignalseverity 0.10

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

74. ?Sep 11, 1:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

75. !Sep 11, 1:20 PMsignalseverity 0.10

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

76. ?Sep 11, 12:50 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    UNH is down 2.42% today with no attributable headline, suggesting institutional flow or sector rotation rather than a news-driven spike that might snap back. The macro context shows 5-year forward inflation expectations elevated at 1.8σ above trend, which broadly pressures rate-sensitive and high-multiple healthcare names like UNH. With 175 minutes remaining there is ample time for continuation, but the absence of a catalyst cuts both ways — no fresh catalyst to accelerate the move, but also no obvious mean-reversion trigger. The move is meaningful enough to reflect real conviction selling. No reversal signals are evident. Probability sits modestly above 0.5 for continuation given the size of the move and macro headwind, but without volume data or a clear sector catalyst, high confidence is not warranted.

77. !Sep 11, 12:50 PMsignalseverity -0.02

    Agent 7 — Day Trader — day_trade_skipped

    UNH is down 2.42% today with no attributable headline, suggesting institutional flow or sector rotation rather than a news-driven spike that might snap back. The macro context shows 5-year forward inflation expectations elevated at 1.8σ above trend, which broadly pressures rate-sensitive and high-multiple healthcare names like UNH. With 175 minutes remaining there is ample time for continuation, but the absence of a catalyst cuts both ways — no fresh catalyst to accelerate the move, but also no obvious mean-reversion trigger. The move is meaningful enough to reflect real conviction selling. No reversal signals are evident. Probability sits modestly above 0.5 for continuation given the size of the move and macro headwind, but without volume data or a clear sector catalyst, high confidence is not warranted.

78. ❖Sep 11, 12:40 PMnewsvia finnhub

    These dow jones stocks are moving in today's session

    Join us in exploring the top gainers and losers within the dow jones index in the middle of the day on Friday as we examine the latest happenings in today's session.

79. ❖Sep 11, 12:35 PMnewsvia finnhub

    Stay informed with the top movers within the S&P500 index on Friday.

    Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session.

80. ?Sep 11, 12:21 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

81. !Sep 11, 12:21 PMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    UNH is down 10.7% from its 30-day high, a meaningful but not extreme dip for a large-cap managed care company with historically strong fundamentals. The drop appears sector-driven rather than company-specific — Health Care (XLV) is underperforming SPY by ~4.24pts over 30 days, suggesting macro/sector headwinds (elevated 10Y yields at 4.83%, rising inflation expectations per the T5YIFR print) rather than a UNH-specific impairment. The TPG deal reshaping Florida WellMed operations is a mild positive (strategic portfolio optimization), and today's broad market tone is risk-on (SPY +1.01%), which could provide a short-term tailwind. However, there are no confirmation signals — no insider cluster buys, no unusual call flow, no analyst upgrades — and the earnings event (Oct 26, 45 days away) with consensus EPS of only $4.13 introduces binary risk in the swing trade window. The Elevance Health margin story and broader managed care headwinds (medical cost ratios, Medicaid redeterminations) suggest sector-wide pressure that may not resolve quickly. The asymmetry profile is weak: upside appears capped at recovering ~12% to the 30-day high rather than a large rebound, and sector fundamentals remain under pressure.

82. ?Sep 11, 12:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

83. !Sep 11, 12:20 PMsignalseverity 0.11

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    UNH is a large-cap, fundamentally sound managed-care name with no evidence of guidance cuts, going-concern language, or fraud in its recent filings. The 10.7% drop does not reach the 15% threshold for a strong mean-reversion signal, and the sector (XLV) is underperforming SPY on both a 5-day and 30-day basis, suggesting this is sector-wide pressure rather than idiosyncratic deterioration. However, earnings are 45 days away (within the 15-30 day penalty window's spirit — not a hard veto but a meaningful headwind), there is no insider buying, no unusual call flow, and the 10Y yield at 4.83% is a structural headwind for healthcare cost-of-capital. Net signal score lands near 0 to +1 (sector underperformance: +1; earnings in ~45 days: no hard veto but mild headwind -1; no cluster buy/unusual calls: no boost; 10Y >4.5%: -1; drop <15%: no bonus; macro mildly adverse), leaving conviction marginal.

84. ❖Sep 11, 12:17 PMnewsvia finnhub

    Can Centene's Medicare Advantage Strategy Unlock Better Margins?

    CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.

85. ❖Sep 11, 9:35 AMnewsvia finnhub

    10 Health Care Stocks With Whale Alerts In Today’s Session

    This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders will

86. ❖Sep 11, 9:33 AMnewsvia finnhub

    UnitedHealth CFO Says ‘We Didn’t Need the Dollars’ As TPG Joins Optum Overhaul

    UnitedHealth sells an Optum Health stake to TPG as it restructures the unit and targets a sharp recovery in operating margins.

87. ❖Sep 11, 9:03 AMnewsvia finnhub

    Trade Tracker: Kevin Simpson buys UnitedHealth

    Kevin Simpson, Capital Wealth Planning founder and CIO, joins CNBC's "Halftime Report" to explain why he's buying UnitedHealth here.

88. ❖Sep 11, 12:08 AMnewsvia finnhub

    $100,000 'Set It And Forget It' Monthly Income Portfolio, Near 7% Yield

    Discover a conservative passive income strategy using six low-leverage BlackRock closed-end funds targeting ~7% yield, with stability in focus—read now.

89. ❖Sep 10, 11:24 PMnewsvia finnhub

    Trump's Surgeon General Pick Has Tobacco, Cola Stocks In Portfolio Even as Robert Kennedy Jr. Wages War On Sugary Drinks, Processed Food

    President Trump&#39;s Surgeon General nominee Dr. Nicole Saphier disclosed investments in Philip Morris and other companies, agreeing to divest if confirmed.

90. ❖Sep 10, 3:36 PMnewsvia finnhub

    Should You Buy Elevance Health Stock For The Margin It Lost?

    Elevance Health (ELV) has returned more than 40% over the past six months, though it is down 6.5% over the past three while the S&P 500 gained 3.4%. The next leg will not come from selling more insurance. It will come from keeping more of the premium it already collects.

91. ❖Sep 10, 1:25 PMnewsvia finnhub

    UnitedHealth Reshapes Florida WellMed Operations With TPG Deal

    UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.

92. ❖Sep 10, 10:39 AMnewsvia finnhub

    Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth?

    CVS is benefiting from pharmacy growth, AI investments and a discounted valuation, but reimbursement pressure and regulatory scrutiny remain key risks.

93. ❖Sep 10, 5:02 AMnewsvia finnhub

    CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom

    CVS Health (NYSE:CVS) executives said the company is seeing improved momentum across its insurance, pharmacy, care delivery and balance-sheet priorities, while maintaining a cautious outlook on healthcare cost trends and several 2027 headwinds. Speaking at an investor conference, Chief Financial Of

94. ❖Sep 10, 3:47 AMnewsvia finnhub

    UnitedHealth Group Incorporated (UNH) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

    UnitedHealth Group Incorporated (UNH) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 8:00 AM EDTCompany ParticipantsJulia Murphy - Vice...

95. ❖Sep 10, 3:02 AMnewsvia finnhub

    UnitedHealth Group Turnaround Gains Steam as Medicare, Optum Trends Improve

    UnitedHealth Group (NYSE:UNH) executives said the company’s turnaround remained on track, citing continued strength in Medicare Advantage, Medicaid performance that is tracking toward the favorable end of expectations, and operational improvements at Optum Health. Speaking at an investor conference

96. ❖Sep 9, 7:24 PMnewsvia finnhub

    UnitedHealth is Removing More Prior Authorizations, Can Simpler Care Pay Off?

    UnitedHealth Group Incorporated’s (NYSE:UNH) insurance unit is removing prior-authorization requirements from a broad range of healthcare services beginning October 1. The changes form part of UnitedHealthcare’s plan to eliminate such requirements for 30% of healthcare services by the end of 2026. The initiative could reduce administrative work for patients, providers, and the insurer itself while […]

97. ❖Sep 9, 5:50 PMnewsvia finnhub

    Why UnitedHealth Group (UNH) Dipped More Than Broader Market Today

    The latest trading day saw UnitedHealth Group (UNH) settling at $393.06, representing a -1.94% change from its previous close.

98. ❖Sep 9, 3:49 PMnewsvia finnhub

    Sector Update: Healthcare Stocks Softer Late Afternoon

    Healthcare stocks were lower late Wednesday afternoon with the NYSE Healthcare Index and the State S

99. ❖Sep 9, 3:30 PMnewsvia finnhub

    Why Is UNH Stock Trading At A Premium With The Slowest Growth?

    UnitedHealth (UNH) runs the best operating margin of the three managed care companies in its peer group, and the slowest revenue growth of the three. It also carries a significant valuation premium over its peer, Cigna, trading at more than double its earnings multiple.

100. ❖Sep 9, 3:10 PMnewsvia finnhub

     Stay informed with the top movers within the dow jones index on Wednesday.

     Curious about the top performers within the dow jones index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

101. ❖Sep 9, 3:06 PMnewsvia finnhub

     Jim Cramer Discusses UnitedHealth’s (UNH) Profitable Growth, and Market Positioning

     On September 3, a caller asked if UnitedHealth Group Incorporated (NYSE:UNH) has enough profitable growth that they should consider adding it to their portfolio. Mad Money host Jim Cramer replied: Yes, the answer: it does, it does. You know, I’ve got to tell you, I thought that last quarter was very, very good. The stock […]

102. ❖Sep 9, 2:05 PMnewsvia finnhub

     CVS Still Sees 'High-Trend' Cost Growth; Oscar, UNH Stock Fall

     CVS Health noted a continuation of "high-trend" medical cost growth at a Wells Fargo investor conference on Wednesday, helping to put a spring in the step of hospital stocks including HCA Healthcare, while souring the mood of managed care investors. Shares of CVS stock came away relatively unscathed, while UnitedHealth slipped and Oscar Health stumbled. CVS management's comments about medical cost trends were brief and vague, while Wells Fargo conference presentations by HCA and Universal Health Services didn't appear to provide updates to Q3 trends since Q2 earnings calls.

103. ❖Sep 9, 1:34 PMnewsvia finnhub

     Sector Update: Healthcare Stocks Decline in Afternoon Trading

     Healthcare stocks were lower Wednesday afternoon, with the NYSE Healthcare Index down 0.3% and the S

104. ❖Sep 9, 1:28 PMnewsvia finnhub

     Why UnitedHealth Stock Is Falling Today

     UnitedHealth's Optum Health Faces Major Shift as TPG Enters the Picture

105. ❖Sep 9, 12:40 PMnewsvia finnhub

     Stay informed with the top movers within the dow jones index on Wednesday.

     Stay informed about the performance of the dow jones index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.

106. ❖Sep 9, 11:30 AMnewsvia finnhub

     Can UnitedHealth's AI Strategy Strengthen Optum Insight's Growth?

     UNH is investing nearly $1.5B in AI to expand Optum Insight's software offerings, boost efficiency and unlock new growth opportunities.

107. ❖Sep 9, 10:40 AMnewsvia finnhub

     UnitedHealth Slips 3% as TPG Buys Into Florida WellMed Clinics Ahead of Guidance Reaffirmation

     TPG just bought into the exact Optum clinics that derailed UnitedHealth's profits, and management is hours away from reaffirming guidance that could either validate the deal or reopen a wound investors hoped was healing.

108. ❖Sep 9, 10:35 AMnewsvia finnhub

     These S&P500 stocks are gapping in today's session

     Let's have a look at the S&P500 gap up and gap down stocks in today's session.

109. ?Sep 9, 9:50 AMdecisionconsidered

     Agent 7 — Day Trader — decide: skip

     UNH is down ~4% today on news of divesting its Florida WellMed clinic interest to TPG, which signals asset shedding and may raise concerns about strategic direction or capital needs. The move is meaningful and represents real selling conviction. However, several factors temper the continuation case: (1) with 355 minutes remaining this is actually early enough in the session that the move could go either way, but it also means there's ample time for continuation selling if institutional players remain active; (2) the macro backdrop shows elevated 5-year forward inflation expectations (1.8σ above trend), which is modestly negative for rate-sensitive/defensive names like UNH as it pressures discount rates and margins; (3) the divestiture headline is ambiguous — could be read as strategic cleanup or as a sign of financial pressure, with the market currently interpreting it negatively; (4) no clear reversal pattern evident — the move appears directional rather than a gap-and-fade. The setup is ordinary momentum without a strong reversal catalyst, and the macro context provides mild additional headwind. Probability slightly above 0.5 — lean continuation but with modest conviction.

110. !Sep 9, 9:50 AMsignalseverity -0.04

     Agent 7 — Day Trader — day_trade_skipped

     UNH is down ~4% today on news of divesting its Florida WellMed clinic interest to TPG, which signals asset shedding and may raise concerns about strategic direction or capital needs. The move is meaningful and represents real selling conviction. However, several factors temper the continuation case: (1) with 355 minutes remaining this is actually early enough in the session that the move could go either way, but it also means there's ample time for continuation selling if institutional players remain active; (2) the macro backdrop shows elevated 5-year forward inflation expectations (1.8σ above trend), which is modestly negative for rate-sensitive/defensive names like UNH as it pressures discount rates and margins; (3) the divestiture headline is ambiguous — could be read as strategic cleanup or as a sign of financial pressure, with the market currently interpreting it negatively; (4) no clear reversal pattern evident — the move appears directional rather than a gap-and-fade. The setup is ordinary momentum without a strong reversal catalyst, and the macro context provides mild additional headwind. Probability slightly above 0.5 — lean continuation but with modest conviction.

111. ❖Sep 9, 4:55 AMnewsvia finnhub

     UnitedHealthcare expects to be ‘very competitive’ in Medicare Advantage next year, CFO says

     The insurer is still working on strategies to ensure its MA markets remain as profitable as possible, but it’s confident in its posture heading into 2027 open enrollment, Wayne DeVeydt said Wednesday.

112. ❖Sep 9, 12:22 AMnewsvia finnhub

     Dr. Mehmet Oz Says 'We're Closing That Door' as CMS Bans 11 Medical Suppliers Over $3.4 Billion in Suspected Fraudulent Medicare Billing

     CMS bars 11 medical equipment suppliers over $3.4 billion in suspected fraudulent Medicare billing involving deceased beneficiaries.

113. ❖Sep 9, 12:12 AMnewsvia finnhub

     'UnitedHealth Sells Interest in Florida WellMed Clinics to TPG' - Bloomberg

     https://www.bloomberg.com/news/articles/2026-09-09/unitedhealth-sells-interest-in-florida-wellmed-clinics-to-tpg 

114. ❖Sep 8, 8:55 PMnewsvia finnhub

     UnitedHealth Sells Interest in Florida WellMed Clinics to TPG

     UnitedHealth Group Inc. has sold an interest in some of its Optum Health operations in Florida to private equity company TPG Inc. as the health conglomerate is working to recover from a collapse in profits last year.

115. ❖Sep 8, 3:10 PMnewsvia finnhub

     Stay informed with the top movers within the dow jones index on Tuesday.

     Let's have a look at the top dow jones gainers and losers one hour before the close of the markets of today's session.

116. ❖Sep 8, 12:40 PMnewsvia finnhub

     What's going on in today's session: dow jones movers

     Wondering what's happening in today's session for the dow jones index? Stay informed with the top movers within the dow jones index on Tuesday.

117. ❖Sep 8, 10:05 AMnewsvia finnhub

     Big Short Billionaire Goes Long: Michael Burry Avoids AI, Bets on Beaten own Stocks Instead

     While Wall Street piles into AI darlings, Michael Burry is quietly loading up on call options in three stocks the market left for dead, and his biggest bets carry a very specific thesis about where the crowd got it wrong.

118. ❖Sep 8, 9:25 AMnewsvia finnhub

     UnitedHealth Group Stock Is Up 39.4% in the Last 6 Months. How High Can It Go?

     While short-term volatility may persist, many signs suggest UnitedHealth Group's turnaround remains in motion.

119. ❖Sep 8, 8:55 AMnewsvia finnhub

     GrabAGun Digital Holdings Inc. Appoints John Swanagon as Chief Technology Officer

     COPPELL, Texas, September 08, 2026--GrabAGun Digital Holdings Inc. Appoints John Swanagon as Chief Technology Officer; Veteran Technology Executive with 30+ Years Experience

120. ❖Sep 7, 9:35 AMnewsvia finnhub

     8 Health Care Stocks Whale Activity In Today’s Session

     This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often

121. ❖Sep 7, 8:45 AMnewsvia finnhub

     $100 Invested In UnitedHealth Group 20 Years Ago Would Be Worth This Much Today

     UnitedHealth Group (NYSE:UNH) has outperformed the market over the past 20 years by 1.51% on an annualized basis producing an average annual return of 10.72%. Currently, UnitedHealth Group has a market capitalization of

122. ?Aug 31, 4:23 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

123. !Aug 31, 4:23 PMsignalseverity 0.11

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

124. ?Aug 31, 4:22 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

125. !Aug 31, 4:22 PMsignalseverity 0.11

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

126. ?Aug 31, 3:24 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

127. !Aug 31, 3:24 PMsignalseverity 0.11

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

128. ?Aug 31, 3:24 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

129. !Aug 31, 3:24 PMsignalseverity 0.11

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

130. ?Aug 31, 2:25 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

131. !Aug 31, 2:25 PMsignalseverity 0.11

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

132. ?Aug 31, 2:24 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

133. !Aug 31, 2:24 PMsignalseverity 0.11

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

134. ?Aug 31, 8:22 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

135. !Aug 31, 8:22 AMsignalseverity 0.10

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

136. ?Aug 28, 4:22 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

137. !Aug 28, 4:22 PMsignalseverity 0.10

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

138. ?Aug 28, 4:22 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

139. !Aug 28, 4:22 PMsignalseverity 0.10

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

140. ?Aug 27, 1:55 PMdecisionconsidered

     Agent 7 — Day Trader — decide: skip

     UNH is down 1.74% today, a meaningful move but just below the 2% threshold where conviction becomes clearer. There is no specific negative catalyst visible in the headlines — the news is generic index/portfolio update content, not UNH-specific. The macro context (elevated mortgage rates at 6.66%, 1.8σ above trend) is directionally negative for rate-sensitive sectors but UNH as a managed care name is not a primary reactor to mortgage rate data. With 110 minutes remaining, there is meaningful time for continuation, but without a clear fundamental driver, the move could reflect broader index pressure or sector rotation rather than UNH-specific conviction. The lack of a strong reversal signal or fade pattern keeps the lean slightly toward continuation of the downward momentum rather than a reversal — large institutional flows that drove this move intraday often persist into the close absent a specific catalyst to reverse them. Probability is set conservatively near the threshold given the absence of confirming news and the moderate (not extreme) magnitude of the move.

141. !Aug 27, 1:55 PMsignalseverity -0.02

     Agent 7 — Day Trader — day_trade_skipped

     UNH is down 1.74% today, a meaningful move but just below the 2% threshold where conviction becomes clearer. There is no specific negative catalyst visible in the headlines — the news is generic index/portfolio update content, not UNH-specific. The macro context (elevated mortgage rates at 6.66%, 1.8σ above trend) is directionally negative for rate-sensitive sectors but UNH as a managed care name is not a primary reactor to mortgage rate data. With 110 minutes remaining, there is meaningful time for continuation, but without a clear fundamental driver, the move could reflect broader index pressure or sector rotation rather than UNH-specific conviction. The lack of a strong reversal signal or fade pattern keeps the lean slightly toward continuation of the downward momentum rather than a reversal — large institutional flows that drove this move intraday often persist into the close absent a specific catalyst to reverse them. Probability is set conservatively near the threshold given the absence of confirming news and the moderate (not extreme) magnitude of the move.

142. ?Aug 27, 7:06 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

143. !Aug 27, 7:06 AMsignalseverity 0.13

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

144. ?Aug 27, 7:06 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

145. !Aug 27, 7:06 AMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

146. ?Aug 26, 4:22 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

147. !Aug 26, 4:22 PMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

148. ?Aug 26, 4:22 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

149. !Aug 26, 4:22 PMsignalseverity 0.13

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

150. ?Aug 26, 3:23 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

151. !Aug 26, 3:23 PMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

152. ?Aug 26, 3:23 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

153. !Aug 26, 3:23 PMsignalseverity 0.13

     Agent 5 — Dip Buyer (Evolving) — dip_skipped

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

154. ?Aug 26, 1:23 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

155. ?Aug 26, 1:23 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

156. ?Aug 26, 12:24 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

157. ?Aug 26, 12:23 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

158. ?Aug 26, 11:25 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

159. ?Aug 26, 11:24 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

160. ✓Aug 26, 9:40 AMdecisionacted

     Agent 7 — Day Trader — decide: buy

     UNH is up 2.01% today, a meaningful intraday move reflecting real institutional flow. With 365 minutes remaining (essentially a full session still ahead), there is ample time for continuation. However, the setup lacks strong catalysts — headlines are generic/retrospective and provide no fresh fundamental driver. The macro context shows 5-year forward inflation expectations elevated at 1.6σ above trend, which is modestly negative for rate-sensitive sectors broadly, but UNH as a managed care/healthcare name is relatively insulated from rate pressure compared to utilities or REITs. No reversal signals are visible — the move appears clean rather than a fade off highs. Absence of a clear news driver is not disqualifying per the framework; momentum itself is evidence. The 2% move suggests real conviction buying. With no strong reason to fade and time remaining to work, a modest continuation bias is warranted, though limited catalyst support and mild macro headwind keep probability in the lower portion of the continuation range.

161. ?Aug 26, 7:05 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

162. ?Aug 26, 7:05 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

163. ▢Aug 25, 8:00 PMjournal

     Agent 7 — Day Trader opened long 7 @ $404.56

164. ▣Aug 25, 8:00 PMjournaltime_stop

     Agent 7 — Day Trader closed long 7 @ $400.71 (-$26.95)

     EOD forced close — day trader never carries overnight

165. ?Aug 25, 4:24 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

166. ?Aug 25, 4:24 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

167. ?Aug 24, 4:24 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

168. ?Aug 24, 4:24 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

169. ?Aug 24, 2:21 PMdecisionconsidered

     Agent 7 — Day Trader — decide: skip

     UNH is up 1.76% today, a meaningful move with real flow behind it. However, several factors temper conviction on continuation: (1) 85 minutes remaining is moderate — enough time for a move, but not ample runway, and the forced close at 3:45 PM ET caps upside duration. (2) The macro context shows the 5-year forward inflation rate running 1.8σ above its 24-month trend, which is a mild headwind for rate-sensitive and large-cap healthcare names as discount rates firm. (3) No clear catalytic headline is driving the move — the only news is a generic Dow gainers/losers recap, which provides no fundamental anchor to sustain buying pressure into the close. (4) At 1.76%, this move is at the lower end of the 'meaningful' range, leaving open the possibility of profit-taking or fading in the final hour. No clear reversal signal is present, and the absence of a specific negative catalyst means the base case remains modest continuation. Probability sits just above the threshold — a borderline long setup where the bounded risk profile justifies entry but without strong conviction.

170. ?Aug 24, 12:25 PMdecisionconsidered

     Agent 7 — Day Trader — decide: skip

     UNH is up ~1.96% today with no attributable headline, suggesting this is flow-driven — likely institutional or sector rotation. With 200 minutes remaining there is ample time for continuation, so the time factor does not penalize the setup. The macro context (T5YIFR elevated at 1.8σ above trend) suggests mild rate pressure, which is modestly negative for managed care multiples but not a strong headwind for a single-session move already in progress. No reversal pattern is evident from the data provided, and absence of news does not disqualify momentum. However, the move is at the lower bound of the 'meaningful' range (~2%), and with no catalyst to point to and a rate environment that is slightly unfavorable to the sector, conviction for a strong continuation call is limited. Assigning a modest continuation probability in the ordinary-momentum range — enough to clear the 0.5 threshold and justify a position with tight stops, but not a high-conviction setup.

171. ?Aug 24, 12:16 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: skip

     Net signal score: -1. UNH is down 14.2% from its 30-day high — just below the +1 mean-reversion threshold of ≥15% — and no hard veto conditions are triggered (no imminent earnings within 14 days, no guidance cut or going-concern language in the 10-Q, and the drop is not >35%). However, the evidence stack is notably headwind-heavy: IRS tax scrutiny headline introduces a real regulatory/legal overhang with uncertain magnitude; political pressure from Senator Warren around breaking up vertical integration represents a structural policy risk; the 10Y yield at 4.65% is above the ~4.5% headwind threshold, applying a -1 signal for this defensive/managed-care name which is nonetheless rate-sensitive through its investment portfolio and cost-of-capital; earnings are 63 days away (clean runway, +1); and sector context is modestly mixed (rank 4 of 11, slight 30d underperformance vs SPY, but today's sector flow is strongly positive at +$19M). Positives: no insider selling, no unusual put activity, low VIX (6th percentile, macro calm), normal yield curve (2s10s +0.46pp), sector not in freefall. Negatives: IRS scrutiny is an active, unquantified fundamental risk (-1 for idiosyncratic negative news), elevated 10Y yield (-1). Net: +1 (earnings runway) -1 (idiosyncratic IRS/regulatory risk) -1 (10Y yield headwind) = -1. With a net score of -1 and an active regulatory/legal overhang, the base rate anchor of 55-60% must be adjusted meaningfully downward.

172. ?Aug 24, 12:16 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     UNH is down 14.2% from its 30-day high, a meaningful but not extreme dip. The drop appears driven by two notable negative catalysts: IRS tax scrutiny (an open-ended regulatory/legal overhang) and Senator Warren's renewed push to break up vertical integration in health care — both are genuine company-specific headwinds, not mere macro noise. The 10-Q was filed with no meaningful disclosed metrics, limiting fundamental reassurance. There are no insider cluster buys, no unusual options call flow, and no analyst upgrade signals to confirm an overreaction thesis. The health care sector is only modestly underperforming (30d -0.99pts vs SPY), meaning this is largely an idiosyncratic drop rather than a sector-wide flush that typically recovers with the sector. Earnings are 63 days away — not imminent — which removes that binary risk, but also means there's no near-term catalyst to reset the narrative. The macro backdrop (VIX at 6th percentile, 10Y at 4.65%) is relatively calm, neither helping nor hurting meaningfully. Without confirmation signals and with two live regulatory/political overhangs, this setup lacks the asymmetric rebound profile the strategy targets.

173. ▣Aug 2, 8:00 PMjournalrotation

     Agent 17 — 52-Week High Momentum closed long 11 @ $415.42 (-$122.32)

     52-Week High monthly rebalance. Position dropped from top 20.

174. ▢Jul 16, 8:00 PMjournal

     Agent 7 — Day Trader opened long 6 @ $432.44

175. ▣Jul 16, 8:00 PMjournaltime_stop

     Agent 7 — Day Trader closed long 6 @ $428.49 (-$23.70)

     EOD forced close — day trader never carries overnight

176. ▢Jul 1, 8:00 PMjournal

     Agent 17 — 52-Week High Momentum opened long 11 @ $426.54